Latest Buprenorphine Stories
LONDON, Jan. 27, 2015 /PRNewswire/ -- INTRODUCTIONOral drug delivery technologies form an integral part of the pharmaceutical industry.
-- Law Enforcement Officers in 13 States Now Carrying EVZIO -- RICHMOND, Va., Jan.
Novel product candidate being studied in treatment of neuropathic pain NEW YORK, Jan. 13, 2015 /PRNewswire/ -- Relmada Therapeutics, Inc.
DUBLIN and RALEIGH, N.C., Dec.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
Novel Product Being Studied to Treat Neuropathic Pain. NEW YORK, Dec. 22, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.
DALLAS, December 12, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Opioids Market Overview to 2023 - Opioids in Emerging Markets" industry research report with latest
Website and Mobile App Offer Comprehensive Array of Information and Resources to Support Patients and Their Families RALEIGH, N.C., Dec.
Data presented from largest combination buprenorphine/naloxone opioid dependence trial ever conducted in the U.S. MORRISTOWN, N.J., Dec. 6, 2014 /PRNewswire/ -- Orexo US, Inc.
- A poem in which the author retracts something said in an earlier poem.